Natrunix or Placebo in Combination With Methotrexate in Rheumatoid Arthritis
Trial details
- Registry ID
- NCT05363891
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as True Human IgG4 monoclonal antibody
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Natrunix or Placebo in Combination With Methotrexate in Rheumatoid ArthritisNCT05363891 | XBIT | Phase 2 | Completed | 2024-10-31Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |